Meribank Biotech Co., Ltd (4724.TWO)
TWD 15.1
(-1.63%)
TWD 15.1
(-1.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.06 Billion TWD | 25.48% |
| 2022 | 846.32 Million TWD | -10.66% |
| 2021 | 947.31 Million TWD | 29.77% |
| 2020 | 729.97 Million TWD | 5.32% |
| 2019 | 693.07 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion TWD | 0.0% |
| 2024 Q1 | 1.22 Billion TWD | 14.97% |
| 2023 Q2 | 771.47 Million TWD | 0.0% |
| 2023 Q1 | 771.47 Million TWD | -8.84% |
| 2023 Q3 | 1.06 Billion TWD | 37.66% |
| 2023 FY | 1.06 Billion TWD | 25.48% |
| 2023 Q4 | 1.06 Billion TWD | 0.0% |
| 2022 Q3 | 846.32 Million TWD | 0.0% |
| 2022 Q4 | 846.32 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 63.39% |
| Level Biotechnology Inc. | 822.67 Million TWD | -29.092% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -59.767% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -93.533% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 72.727% |
| GlycoNex Incorporation | 1.55 Billion TWD | 31.608% |
| VBI | 452.1 Million TWD | -134.905% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 9.704% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -41.871% |
| Visgeneer Inc. | 397.17 Million TWD | -167.39% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 71.833% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 50.811% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -20.26% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 82.569% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1343.77% |
| Enimmune corporation | 604.82 Million TWD | -75.589% |
| TaiRx, Inc. | 833.74 Million TWD | -27.378% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 65.587% |
| EirGenix Inc. | 11.16 Billion TWD | 90.486% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -85.297% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 37.98% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 70.473% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -1.097% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -252.789% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -301.277% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -140.714% |
| RBC Bioscience Corporation | 753.79 Million TWD | -40.889% |
| BiOptic Inc. | 613.77 Million TWD | -73.029% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 40.292% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 8.425% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -64.691% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 65.811% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -729.389% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -180.686% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 6.336% |
| Neith Corporation | 192.15 Million TWD | -452.689% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -617.893% |
| NaviFUS Corp. | 490.53 Million TWD | -116.5% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 13.356% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 22.104% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -100.702% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 8.557% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 35.88% |
| AP Biosciences Inc | 890.75 Million TWD | -19.225% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 87.546% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -227.631% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 20.368% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 60.827% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 93.088% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -158.863% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -167.609% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 48.842% |
| TCI GENE Inc. | 1.16 Billion TWD | 8.914% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -260.515% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 22.102% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -12.768% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -52.052% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 73.14% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 72.218% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 13.647% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 81.049% |
| Acepodia, Inc. | 6.81 Billion TWD | 84.425% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 72.246% |